Taipei Medical University BioMed Accelerator and BE Health Ventures have co-launched TMU X BE Accelerator Program, which is a Proof of Clinical Evidence Program that focuses on product or prototype-ready startups that are looking for traction in the Asian market.  Based in Taipei, Taiwan we leverage the unique strengths of our ecosystem to position our accelerator program as the gateway to Asia.

Within the program, startups would have opportunity to access the hospital facilities, research institutes, investors, healthcare experts and other industry stakeholders help you secure funding and expand your market to US , Japan and SEA.
 
For details, please click the following URL: https://bit.ly/TMU2023Batch